{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:20:10Z","timestamp":1762161610325,"version":"3.41.2"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2020.598056","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T06:51:34Z","timestamp":1604991094000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Laquinimod Inhibits Inflammation-Induced Angiogenesis in the Cornea"],"prefix":"10.3389","volume":"7","author":[{"given":"Zuohong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehong","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenru","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1043\/0003-9985(2001)125<0067:ROLAEC>2.0.CO;2","article-title":"Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing","volume":"125","author":"Lingen","year":"2001","journal-title":"Arch Pathol Lab Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1167\/iovs.08-2805","article-title":"Bevacizumab application delays epithelial healing in rabbit cornea","volume":"50","author":"Kim","year":"2009","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature."},{"key":"B4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/09273948.2010.501946","article-title":"Reviews for immune privilege in the year 2010: immune privilege and infection","volume":"18","author":"Hazlett","year":"2010","journal-title":"Ocul Immunol Inflamm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/j.1349-7006.2008.00853.x","article-title":"Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy","volume":"99","author":"Ono","year":"2008","journal-title":"Cancer Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ncb2331","article-title":"VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling","volume":"13","author":"Tammela","year":"2011","journal-title":"Nat Cell Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2353\/ajpath.2006.050255","article-title":"Monocytes\/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles","volume":"168","author":"Anghelina","year":"2006","journal-title":"Am J Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1167\/iovs.11-8010","article-title":"The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages","volume":"53","author":"Maruyama","year":"2012","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J Clin Invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1021\/jm031044w","article-title":"Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship","volume":"47","author":"J\u00f6nsson","year":"2004","journal-title":"J Med Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/art.38259","article-title":"Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells","volume":"66","author":"Louren\u00e7o","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/gutjnl-2014-307118","article-title":"A phase II study of laquinimod in crohn's disease","volume":"64","author":"D'Haens","year":"2015","journal-title":"Gut."},{"key":"B15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/jnc.13553","article-title":"Laquinimod dampens hyperactive cytokine production in huntington's disease patient myeloid cells","volume":"137","author":"Dobson","year":"2016","journal-title":"J Neurochem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00415-014-7264-4","article-title":"A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis","volume":"261","author":"Vollmer","year":"2014","journal-title":"J Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/jnnp-2013-306132","article-title":"Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage","volume":"85","author":"Filippi","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1056\/NEJMoa1104318","article-title":"Placebo-controlled trial of oral laquinimod for multiple sclerosis","volume":"366","author":"Comi","year":"2012","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ajpath.2012.05.011","article-title":"Kinetics of pro-inflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod","volume":"181","author":"Mishra","year":"2012","journal-title":"Am J Pathol."},{"key":"B20","unstructured":"Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo34961\n            LuY\n            ZhengY\n            AiJ\n            XuX\n          27355331Discov Med212016"},{"key":"B21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/00007890-196411000-00001","article-title":"Evaluation of the trypan blue technique for determination of cell viability","volume":"2","author":"Tennant","year":"1964","journal-title":"Transplantation."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.intimp.2006.07.003","article-title":"Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1","volume":"6","author":"Lin","year":"2006","journal-title":"Int Immunopharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jvs.2011.07.072","article-title":"High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury","volume":"55","author":"Sachdev","year":"2012","journal-title":"J Vasc Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1038\/srep07319","article-title":"Enhancement of electron-hole superfluidity in double few-layer graphene","volume":"4","author":"Zarenia","year":"2014","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/eji.1830111013","article-title":"F4\/80, a monoclonal antibody directed specifically against the mouse macrophage","volume":"11","author":"Austyn","year":"1981","journal-title":"Eur J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"E7239","DOI":"10.1073\/pnas.1500396113","article-title":"CD11b regulates obesity-induced insulin resistance via limiting alternative activation and proliferation of adipose tissue macrophages","volume":"112","author":"Zheng","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/jlb.55.3.410","article-title":"Macrophages and angiogenesis","volume":"55","author":"Sunderk\u00f6tter","year":"1994","journal-title":"J Leukoc Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"H719","DOI":"10.1152\/ajpheart.00933.2009","article-title":"A microfluidic wound-healing assay for quantifying endothelial cell migration","volume":"298","author":"van der Meer","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10555-007-9094-7","article-title":"Tumour vascularization: sprouting angiogenesis and beyond","volume":"26","author":"Hillen","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.brainresbull.2009.05.019","article-title":"Corneal transparency: genesis, maintenance and dysfunction","volume":"81","author":"Qazi","year":"2010","journal-title":"Brain Res Bull."},{"key":"B32","first-page":"214","article-title":"Corneal blindness: a global perspective","volume":"79","author":"Whitcher","year":"2001","journal-title":"Bull World Health Organ."},{"key":"B33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2174\/187221309789257450","article-title":"Corneal neovascularization: molecular events and therapeutic options","volume":"3","author":"Shakiba","year":"2009","journal-title":"Recent Pat Inflamm Allergy Drug Discov."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1097\/ICO.0000000000000220","article-title":"Effects of subconjunctival tocilizumab versus bevacizumab in treatment of corneal neovascularization in rabbits","volume":"33","author":"Yoo","year":"2014","journal-title":"Cornea."},{"key":"B35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00417-014-2626-2","article-title":"Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis","volume":"252","author":"Lipp","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/02713680903429007","article-title":"Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model","volume":"35","author":"Avisar","year":"2010","journal-title":"Curr Eye Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye."},{"key":"B38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00417-014-2851-8","article-title":"Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab","volume":"253","author":"Dekaris","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2353\/ajpath.2010.090678","article-title":"Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury","volume":"176","author":"Leedom","year":"2010","journal-title":"Am J Pathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":"Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10456-007-9074-0","article-title":"Angiogenesis and chronic inflammation: cause or consequence","volume":"10","author":"Costa","year":"2007","journal-title":"Angiogenesis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1167\/iovs.14-16012","article-title":"M2 macrophages enhance pathological neovascularization in the mouse model of oxygen-induced retinopathy","volume":"56","author":"Zhou","year":"2015","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2017.10.011","article-title":"Recent advances in inflammasome biology","volume":"50","author":"Place","year":"2018","journal-title":"Curr Opin Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"14867","DOI":"10.1073\/pnas.1111101108","article-title":"NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy","volume":"108","author":"Jin","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B45","first-page":"3698","article-title":"Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice","volume":"59","author":"Tartour","year":"1999","journal-title":"Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2006.09.002","article-title":"Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy","volume":"26","author":"Zhang","year":"2007","journal-title":"Prog Retin Eye Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1359-6446(01)02160-2","article-title":"Tipping the balance for angiogenic disorders","volume":"7","author":"Gao","year":"2002","journal-title":"Drug Discov Today."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1167\/iovs.03-0940","article-title":"Roles of thrombospondin-1 and\u22122 in regulating corneal and iris angiogenesis","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature."},{"key":"B50","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","article-title":"Basic and therapeutic aspects of angiogenesis","volume":"146","author":"Potente","year":"2011","journal-title":"Cell."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.598056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T06:51:40Z","timestamp":1604991100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.598056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":50,"alternative-id":["10.3389\/fmed.2020.598056"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.598056","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"article-number":"598056"}}